Researchers across the world have already amassed tons of info about COVID-19, and learn more every day. Now, Berkeley Lab experts are developing a platform that puts all this valuable knowledge in one place, and leverages machine learning to make new discoveries.
Our biomanufacturing experts are helping accelerate the development of new COVID-19-fighting technologies. Learn how the scientists at the ABPDU are collaborating with biotech companies to scale up and optimize production of coronavirus-targeting antibodies and a highly accurate rapid testing system.
Even an underground experiment 4,600 feet below a mountain in Central Italy, and a telescope instrument more than a mile high atop an Arizona mountaintop could not escape the impacts of the COVID-19 pandemic. In these videos, a Berkeley Lab scientist and two Berkeley Lab-affiliated researchers share their experiences of working in international collaborations during the COVID-19 pandemic.
Scientists at Berkeley Lab’s Molecular Foundry have joined forces with a research team at Stanford to aim a gene-targeting, antiviral agent called PAC-MAN against COVID-19.
A technology spun from carbon nanotube sensors discovered 20 years ago by Berkeley Lab scientists could one day help health care providers test patients for COVID-19, the disease caused by the coronavirus SARS-CoV-2.
One of the many unanswered scientific questions about COVID-19 is whether it is seasonal like the flu – waning in warm summer months then resurging in the fall and winter. Now scientists at Lawrence Berkeley National Laboratory are launching a project to apply machine-learning methods to a plethora of health and environmental datasets, combined with high-resolution climate models and seasonal forecasts, to tease out the answer.
An international scientific team has discovered a neutralizing antibody, derived from the blood of a SARS survivor, that inhibits the closely related COVID-19-causing coronavirus. In a paper published this week in Nature, the scientists note that the antibody is already on an accelerated development path toward clinical trials.
David Richardson’s job is literally to make sure the light stays on. But it’s not just any light – it’s a very special X-ray light that could play a crucial role in an eventual treatment for COVID-19. Richardson is an operator at the Advanced Light Source, and is one of a handful of workers providing essential services to scientists working on COVID-19-related research.
As society prepares to reopen indoor spaces and ease back into some sense of normalcy during the COVID-19 pandemic, a team of researchers at Berkeley Lab is launching a study of the risk of airborne transmission of viruses within buildings and how to mitigate those risks.
A team of materials scientists at Berkeley Lab – scientists who normally spend their time researching things like high-performance materials for thermoelectrics or battery cathodes – have built a text-mining tool in record time to help the global scientific community synthesize the mountain of scientific literature on COVID-19 being generated every day.